C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/1999
10/28/1999	WO1999040180A3 Expanded and genetically modified populations of human hematopoietic stem cells
10/28/1999	WO1999037786A3 Methods and compositions for modifying levels of secondary metabolic compounds in plants
10/28/1999	WO1999037763A9 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
10/28/1999	WO1999035243A9 Extension of cellular lifespan, methods and reagents
10/28/1999	WO1999032516A3 Pharmaceutical compositions containing the long pentraxin ptx3
10/28/1999	WO1999027080A3 Human protein kinase and kinase inhibitors
10/28/1999	WO1998044104A3 Flip gene and flip protein
10/28/1999	DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents
10/28/1999	DE19818619A1 New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents
10/28/1999	DE19817947A1 New nucleic acid sequences expressed in uterine myoma, and derived polypeptides, for treatment of uterine carcinoma and identification of therapeutic agents
10/28/1999	CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999	CA2328888A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999	CA2328463A1 Matrix binding factor
10/28/1999	CA2326823A1 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
10/28/1999	CA2326689A1 Stress tolerant plants
10/28/1999	CA2326623A1 Gene encoding syntaxin interacting protein
10/28/1999	CA2326067A1 Novel insecticidal toxins from xenorhabdus nematophilus and nucleic acid sequences coding therefor
10/28/1999	CA2325864A1 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy
10/28/1999	CA2325848A1 B-cell growth factor related protein
10/28/1999	CA2325822A1 Soluble protein ztmpo-1
10/28/1999	CA2325663A1 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
10/28/1999	CA2325573A1 A method for inhibiting tumor invasion or spreading in a subject
10/28/1999	CA2325561A1 Combination therapy using nucleic acids and conventional drugs
10/28/1999	CA2325391A1 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999	CA2324975A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999	CA2324442A1 Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata
10/28/1999	CA2324297A1 Sh2 domain-containing peptides
10/28/1999	CA2323571A1 Novel human k+ ion channel and therapeutic applications thereof
10/27/1999	EP0952224A2 Method for producing transgenic cucumber that produces high levels of superoxide dismutase
10/27/1999	EP0952218A2 Single chain, multiple antigen-binding molecule, its preparation and use
10/27/1999	EP0952214A1 Aviadenovirus
10/27/1999	EP0952213A2 Process for inducing an immune response mediated by NK-cells
10/27/1999	EP0951568A1 Methods for detecting and inhibiting the rna component of telomerase
10/27/1999	EP0951563A1 A new eia test using non-dentured hiv antigen for early detection of hiv infection
10/27/1999	EP0951557A1 Methods for generating and screening novel metabolic pathways
10/27/1999	EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999	EP0951554A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
10/27/1999	EP0951551A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
10/27/1999	EP0951550A1 Mammalian cytokine related to il10
10/27/1999	EP0951549A1 Mammalian chemokines
10/27/1999	EP0951545A2 Human gtp-binding proteins
10/27/1999	EP0951543A1 Human glycine transporter
10/27/1999	EP0951542A2 Secreted proteins and polynucleotides encoding them
10/27/1999	EP0951540A2 Antisense nucleic acids and hammerhead ribozymes
10/27/1999	EP0951537A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
10/27/1999	EP0951534A1 Nucleic acid sequence encoding beta-c-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin
10/27/1999	EP0951533A1 Vectors and methods for the mutagenesis of mammalian genes
10/27/1999	EP0951532A1 Bivalent agonists for g-protein coupled receptors
10/27/1999	EP0951469A1 Novel compounds
10/27/1999	EP0759938A4 Neurogenic differentiation (neurod) genes and proteins
10/27/1999	EP0539525B1 Vitaletheine and use in cell culture and therapy
10/27/1999	EP0533862B1 Recombinant human factor viii derivatives
10/27/1999	CN1233290A Antifungal proteins, DNA coding therefore, and hosts incorporating same
10/27/1999	CN1233187A HIVp-17 peptide fragment, compositions containing and methods for producing and using same
10/27/1999	CN1233185A Nucleosome-based anti-tumor compositions
10/27/1999	CN1233171A Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
10/27/1999	CN1232874A High-transfer human liver cancer cell line and its establishment process
10/27/1999	CN1045995C Method of inducing lysine overproduction in plants
10/26/1999	US5973230 Pinosylvine synthase genes
10/26/1999	US5973133 Mutant S182 genes
10/26/1999	US5973123 Monoclonal antibody, or fragment thereof, which has an affinity for native melanoma inhibitory activity protein
10/26/1999	US5973119 Cyclin E genes and proteins
10/26/1999	US5972923 Methods and compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants
10/26/1999	US5972902 DNA encoding human IL-6 receptor antagonist and protein encoded thereby
10/26/1999	US5972901 Making a composition for delivering an oligonucleotide to a mammalian cell by providing a peptide target binding moiety being capable of binding to a serpin enzyme complex receptor, polylysine, an oligonucleotide vector; conjugating, coupling
10/26/1999	US5972886 Amino acid sequences, a gene coding for stimulating cell differentiation of megakaryocytes; increasing blood platelet cells
10/26/1999	US5972708 Plasmid stabilization
10/26/1999	US5972703 Both simple fractures and medically complicated breaks would benefit from novel therapeutic modalities which accelerate and/or complete the repair process.
10/26/1999	US5972679 The identification and isolation of extracellular polypeptides which are associated with plant frost or cold tolerance and their use in mitigating the effects of frost and controlling crystalline growth of ice.
10/26/1999	US5972676 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
10/26/1999	US5972674 May be used, for example, to identify antibodies and other agents that inhibit or activate signal transduction via the nf-.kappa.b cascade.
10/26/1999	US5972666 Assembly-deficient herpesvirus vaccine
10/26/1999	US5972664 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
10/26/1999	US5972652 Polynucleotides encoding secreted proteins
10/26/1999	US5972651 Polynucleotides and polypeptides of the fifty-four homologue family, (ffh); vectors and transformed host cells; ffh are components of protein secretory apparatus and their inhibition of function is deleterious to bacteria cells
10/26/1999	US5972650 Can be used as vehicles for the delivery of nucleic acids that can serve as therapeutic agents and as part of vaccines designed to immunize people or animals against viral diseases.
10/26/1999	US5972649 Polynucleotide sequence encoding human multiple endocrine neoplasia type 1 protein
10/26/1999	US5972646 Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor
10/26/1999	US5972627 Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells obtained thereby
10/26/1999	US5972623 Collagen-peptide assay method
10/26/1999	US5972609 Utrophin gene promotor
10/26/1999	US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/26/1999	US5972597 Methods using modified vaccinia virus
10/26/1999	US5972596 Nucleic acid constructs containing HIV genes with mutated inhibitory/instability regions and methods of using same
10/26/1999	US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999	US5972332 Enhancing the healing of wounds, especially chronic wounds (e.g., diabetic wounds), are provided involving the use of keratinocytes
10/21/1999	WO1999053310A1 Antigen
10/21/1999	WO1999053100A2 Method for finding genetic markers of somaclonal variation
10/21/1999	WO1999053085A2 Selective regulation of adenovirus production
10/21/1999	WO1999053078A2 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
10/21/1999	WO1999053077A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999	WO1999053076A1 Tao protein kinases and methods of use therefor
10/21/1999	WO1999053070A1 Flowering locus t (ft) and genetically modified plants having modulated flower development
10/21/1999	WO1999053067A2 Seed-coat promoters, genes and gene products
10/21/1999	WO1999053066A1 U4, a member of the hematopoietin receptor superfamily
10/21/1999	WO1999053062A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
10/21/1999	WO1999053061A2 Tumor associated nucleic acids and uses therefor
10/21/1999	WO1999053060A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999	WO1999053059A1 Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence
10/21/1999	WO1999053058A1 Vertebrate patched-2 protein

1 ... 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 ... 1827